Related Experiment Video

Updated: Mar 17, 2026

"Liver-on-a-Chip" Cultures of Primary Hepatocytes and Kupffer Cells for Hepatitis B Virus Infection
10:25

"Liver-on-a-Chip" Cultures of Primary Hepatocytes and Kupffer Cells for Hepatitis B Virus Infection

Published on: February 19, 2019

12.3K

Analysis of polymorphism and hepatic expression of duodenal cytochrome b in chronic hepatitis C

Alina Rudnicka1, Anna Woziwodzka1, Anna Wróblewska1

  • 1Department of Molecular Diagnostics, Intercollegiate Faculty of Biotechnology, University of Gdansk-Medical University of Gdansk, Gdansk, Poland.

Journal of Gastroenterology and Hepatology
|July 21, 2016
PubMed

Insights

The duodenal cytochrome b gene (CYBRD1) variant rs884409 is linked to increased iron overload, inflammation, and oxidative stress in chronic hepatitis C patients. This implicates CYBRD1 in the disease

Area of Science:

  • Hepatology
  • Genetics
  • Molecular Biology

Background:

  • Pathological iron overload is a common negative prognostic factor in chronic hepatitis C (CHC).
  • A single nucleotide polymorphism (SNP) rs884409 in the duodenal cytochrome b gene (CYBRD1) is associated with hemochromatosis.
  • The role of CYBRD1 in iron overload within CHC patients requires further investigation.

Purpose of the Study:

  • To investigate the impact of CYBRD1 genotype and expression on iron overload in CHC patients.
  • To analyze the association between SNP rs884409 and iron homeostasis markers.
  • To examine the correlation between CYBRD1 expression and iron-related gene regulators.

Main Methods:

  • Analysis of liver biopsy and whole blood samples from 243 CHC patients.
  • Assessment of hepatic iron deposits, serum iron markers, and iron homeostasis gene expression.
  • Genotyping for CYBRD1 SNP rs884409 and quantitative gene expression analysis.

Main Results:

  • The rs884409 G allele correlated with elevated serum iron, liver inflammation, and oxidative stress.
  • Hepatic CYBRD1 expression was linked to Tfr2, Id1, and HO-1 gene expression.
  • Increased CYBRD1 expression was associated with higher serum ferritin and hepatic iron accumulation.

Conclusions:

  • CYBRD1 plays a significant role in iron homeostasis in the context of chronic hepatitis C.
  • The CYBRD1 SNP rs884409 may serve as a genetic marker for iron overload in CHC.
  • CYBRD1 expression levels are indicative of iron accumulation and associatedpathological processes in CHC.
Abstract

Keywords:
CHCCYBRD1SNPiron overload

More Related Videos

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice09:03

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice

Published on: February 3, 2012

20.0K
A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target11:34

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

Published on: May 10, 2022

2.8K

Related Concept Videos

Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes01:28

Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes

Cytochrome P450 (CYP450) enzymes are a superfamily of heme-containing monooxygenases that play a pivotal role in Phase I drug metabolism by catalyzing oxidation and reduction reactions.These enzymes transform lipophilic xenobiotics into more hydrophilic metabolites, facilitating subsequent Phase II conjugation and eventual excretion. The CYP450 family is classified into families (e.g., CYP1–CYP3) and subfamilies (e.g., CYP2A, CYP2C), based on amino acid sequence homology.CYP450...
102
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
315
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
248
Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug01:14

Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug

In pharmacotherapy, monitoring drug concentrations is paramount, especially for drugs whose therapeutic effects hinge on both the active compound and its metabolite. Hepatic impairment profoundly influences drug potency by altering liver function. If the drug is more potent than its metabolite, impaired liver function amplifies drug activity due to elevated drug concentration levels. Conversely, if the metabolite holds greater potency, diminished liver function diminishes drug activity by...
278
Hepatic Drug Excretion: Influencing Factors01:16

Hepatic Drug Excretion: Influencing Factors

The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
706
Pharmacogenetics of Drug Metabolism: Overview01:27

Pharmacogenetics of Drug Metabolism: Overview

Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...
90